6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade
Steatosis
Hepatocyte nuclear factors
Lipid droplet
DOI:
10.1016/j.jcmgh.2021.06.007
Publication Date:
2021-06-15T23:07:20Z
AUTHORS (7)
ABSTRACT
Background & AimsThe development of nonalcoholic fatty liver disease (NAFLD) can be modulated by microRNAs (miRNA). Dietary polyphenols modulate the expression miRNA such as miR-467b-3p in liver. In addition, 6-gingerol (6-G), functional polyphenol ginger, has been reported to ameliorate hepatic steatosis; however, exact mechanism involved and role remain elusive. this study, we assessed pathogenesis steatosis regulation 6-G through hepatocyte nuclear factor 4α (HNF4α).MethodsmiR-467b-3p was measured free acid (FFA)-treated hepatocytes or from high-fat diet (HFD)-fed mice. Gain- loss-of-function induced using miR-467b-3p–specific mimic inhibitor, respectively. exposed FFA-treated cells HFD-fed The HNF4α/miR-467b-3p/GPAT1 axis mouse human tissues.ResultsWe found that down-regulated tissues mice Hepa1-6 cells. Overexpression decreased intracellular lipid accumulation mitigated via negative glycerol-3-phosphate acyltransferase-1 (GPAT1). up-regulation observed. inhibited FFA-induced steatosis. Moreover, it increased transcriptional activity HNF4α, resulting increase subsequent decrease GPAT1. signaling also observed samples with steatosis.ConclusionsOur findings establish a novel which improves NAFLD. This suggests targeting cascade may used potential therapeutic strategy control (HNF4α). tissues. We Our
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (21)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....